A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma

This retrospective analysis aimed to establish the overall cardiac safety profile of bortezomib using patient-level data from one phase 2 and seven phase 3 studies in previously untreated and relapsed/refractory multiple myeloma [MM]. Seven clinically relevant primary (congestive heart failure [CHF]...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Haematol
Main Authors: Laubach, Jacob P., Moslehi, Javid J., Francis, Sanjeev A., Miguel, Jesús F. San, Sonneveld, Pieter, Orlowski, Robert Z., Moreau, Philippe, Rosiñol, Laura, Faber, Edward A., Voorhees, Peter, Mateos, Maria-Victoria, Marquez, Loreta, Feng, Huaibao, Desai, Avinash, van de Velde, Helgi, Elliott, Jennifer, Shi, Hongliang, Dow, Edward, Jobanputra, Nishith, Esseltine, Dixie-Lee, Niculescu, Liviu, Anderson, Kenneth C., Lonial, Sagar, Richardson, Paul G.
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6812508/
https://ncbi.nlm.nih.gov/pubmed/28466536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.14708
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker